Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target
Since its discovery in the 1990s, “programmed cell death protein 1,” or PD-1, has been regarded as a leading target in cancer treatments. A “checkpoint” receptor that often resides on…